Table 1. Clinical characteristics of the individuals in the study.

Patient outcome	SEX	AGE	ALT (at time of lymphocyte collection)	HCV-RNA Copies/mL	Genotype	HLA-C group
Chronic 1	F	64	417	3,100	2	1,2
Chronic 2	M	29	875	12,897,741	2	2,2
Chronic 3	M	29	245	16,242	3	2,2
Chronic 4	M	44	852	451,916	1A	1,2
Chronic 5	M	18	1114	6,775,737	3	1,1
Chronic 6	M	67	490	10,170	2	1,1
Chronic 7	F	33	34	<3200	1	ND
Chronic 8	M	57	1027	1,344,724	2	1,2
Chronic 9	M	25	146	528,241	1A/1B	1,2
Chronic 10	M	22	358	ND	3	2,2
Chronic 11	M	22	459	3,807	3	1,1
Chronic 12	F	41	225	1,361,225	1A	ND
Chronic 13	MM	39	210	3,1 998	1B	ND
Chronic 14	F	50	78	ND	2C	ND
Self-limited 1	F	50	567	5,517	1	ND
Self-limited 2	F	52	67	1,030,000	1	1,2
Self-limited 3	M	20	1299	<3200	n/a	1,2
Self-limited 4	M	28	152	4,957	n/a	1,2
Self-limited 5	M	18	54	12,991	4	1,2
Self-limited 6	M	27	54	ND	1	2,2
Self-limited 7	M	32	940	7,355	2	1,1
Self-limited 8	F	25	1966	240,807	n/a	1,2